Balchem Co. (NASDAQ:BCPC) Shares Sold by Moody Aldrich Partners LLC

Moody Aldrich Partners LLC decreased its holdings in shares of Balchem Co. (NASDAQ:BCPC) by 3.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 28,741 shares of the basic materials company’s stock after selling 921 shares during the quarter. Moody Aldrich Partners LLC’s holdings in Balchem were worth $4,685,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Westside Investment Management Inc. purchased a new stake in Balchem during the 3rd quarter worth about $27,000. nVerses Capital LLC purchased a new stake in Balchem during the 3rd quarter worth about $35,000. Wilmington Savings Fund Society FSB purchased a new stake in Balchem during the 3rd quarter worth about $35,000. Blue Trust Inc. lifted its holdings in Balchem by 642.5% during the 3rd quarter. Blue Trust Inc. now owns 839 shares of the basic materials company’s stock worth $148,000 after buying an additional 726 shares during the last quarter. Finally, GAMMA Investing LLC lifted its holdings in Balchem by 73.4% during the 3rd quarter. GAMMA Investing LLC now owns 841 shares of the basic materials company’s stock worth $148,000 after buying an additional 356 shares during the last quarter. Institutional investors and hedge funds own 87.91% of the company’s stock.

Balchem Stock Up 0.1 %

Balchem stock opened at $161.03 on Wednesday. The company has a market capitalization of $5.23 billion, a P/E ratio of 43.29, a PEG ratio of 4.36 and a beta of 0.69. Balchem Co. has a fifty-two week low of $137.69 and a fifty-two week high of $186.03. The stock has a 50-day simple moving average of $168.26 and a 200-day simple moving average of $170.87. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.90 and a current ratio of 2.98.

Balchem Increases Dividend

The business also recently declared an annual dividend, which was paid on Friday, January 17th. Investors of record on Thursday, December 26th were given a $0.87 dividend. This represents a yield of 0.4%. The ex-dividend date of this dividend was Thursday, December 26th. This is a boost from Balchem’s previous annual dividend of $0.79. Balchem’s payout ratio is 23.39%.

Wall Street Analysts Forecast Growth

BCPC has been the subject of several research reports. HC Wainwright boosted their target price on Balchem from $185.00 to $190.00 and gave the company a “buy” rating in a report on Monday, November 4th. StockNews.com raised Balchem from a “hold” rating to a “buy” rating in a report on Monday, October 28th.

Balchem Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.